Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Oslo Bors  >  PCI Biotech Holding ASA    PCIB   NO0010405640

PCI BIOTECH HOLDING ASA

(PCIB)
  Report
Real-time Estimate Quote. Real-time Estimate CHI-X - 07/07 05:18:46 am
71.1 NOK   -0.28%
05/27PCI BIOTECH : Minutes from Annual General Meeting 2020
GL
05/06PCI BIOTECH : Notice of Annual General Meeting 2020
GL
05/06PCI BIOTECH : Q1 2020 Interim Report
PU
SummaryQuotesChartsNewsCalendarCompanyFinancials 
Business Summary
Logo PCI Biotech Holding ASA
PCI Biotech Holding ASA is a Norway-based company engaged in the biotechnology sector. Its activities are focused on the commercialization of a patented photochemical drug delivery technology for use in the localized cancer treatment. The Company’s products are based on the Photochemical Internalization (PCI) technology for light-directed drug delivery, used to enhance the effect of drugs by targeted illumination of the diseased areas of the body. It focuses primarily on the drug candidate Amphinex, developed for treatment of head and neck cancer and bile duct cancer, as well as on the development of PCI for vaccination. As of December 31, 2011, it had a wholly owned subsidiary PCI Biotech AS and an affiliate PCIO Biotech Utibu, located in Iceland.

Number of employees : 12 people.
Managers
NameAgeSinceTitle
Per Walday, Dr.592008Chief Executive Officer
Hans Peter Bøhn, Dr.642015Chairman
Ronny Skuggedal432013Chief Financial Officer
Anders Høgset, Dr.652001Chief Scientific Officer
Amir Snapir, Dr.-2020Chief Medical Officer
Christina Elisabeth Herder, Dr.582015Independent Director
Lars Kåre Viksmoen, Dr.712016Independent Director
Hilde Furberg612019Director
Andrew Hughes, Dr.-2018Independent Director
Kristin Eivindvik58-Chief Development Officer
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 37,265,890 24,266,090 65.1% 0 0.0% 65.1%
Shareholders
NameEquities%
Must Family 3,760,443 10.1%
Myrlid AS 2,438,000 6.54%
MP Pensjon PK 2,258,206 6.06%
Radiumhospitalets Forskningsstiftelse 1,281,415 3.44%
Odd Roar Gresslien 721,000 1.93%
Kjetil Myrlid Aasen 500,000 1.34%
Alexander Berg-Larsen 493,450 1.32%
Ducra Holding AS 376,000 1.01%
KLP Kapitalforvaltning AS 373,317 1.00%
FORENEDE FORVALTNING AS 306,166 0.82%
Company contact information
PCI Biotech Holding ASA
Ullernchauséen 64
Oslo 0379

Phone : +47.67.11.54.00
Fax : +47.67.11.54.01
Web : http://www.pcibiotech.no
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
PCI BIOTECH HOLDING ASA-1.96%295
GILEAD SCIENCES, INC.17.50%95 771
VERTEX PHARMACEUTICALS32.95%75 475
REGENERON PHARMACEUTICALS65.77%63 212
WUXI APPTEC CO., LTD.42.86%31 226
GENMAB A/S49.85%21 887
BEIGENE, LTD.18.16%15 294
BIONTECH SE86.75%14 348
SAREPTA THERAPEUTICS, INC.26.12%12 693
HUALAN BIOLOGICAL ENGINEERING INC.71.61%12 232
NEUROCRINE BIOSCIENCES, INC.16.63%11 643
ARGENX SE46.52%11 119
EXELIXIS, INC.33.26%7 200
ASCENDIS PHARMA A/S8.54%6 676
BIOCON LIMITED36.82%6 282
ZAI LAB LIMITED95.00%6 056
ACCELERON PHARMA INC.91.15%5 948
PEPTIDREAM INC.-16.07%5 644
REATA PHARMACEUTICALS, INC.-22.79%5 247
ULTRAGENYX PHARMACEUTICAL INC.101.45%5 141
MIRATI THERAPEUTICS, INC.-9.21%5 106